发明名称 |
Direct Lipid to Membrane Drug Delivery |
摘要 |
Described herein is a method of delivering hydrophilic drugs directly from a hydrophobic carrier and/or excipient to absorbing cell membranes. More specifically, CaNa2 EDTA is delivered rectally from a suppository containing methylbutylketone in a carrier as an excipient. |
申请公布号 |
US2014275259(A1) |
申请公布日期 |
2014.09.18 |
申请号 |
US201414207424 |
申请日期 |
2014.03.12 |
申请人 |
APPLIED BIORESEARCH, INC. |
发明人 |
Palmer James F.;Settineri Robert A. |
分类号 |
A61K31/198 |
主分类号 |
A61K31/198 |
代理机构 |
|
代理人 |
|
主权项 |
1. A suppository for use in chelating heavy metals in a living being comprising:
i. calcium disodium ethylenediaminetetraacetate (CaNa2 EDTA), ii. a hydrophobic excipient, and iii. a carrier comprising one or more of glycerin, glyceryl monopalmitate, glyceryl monostearate, hydrogenated coconut oil fatty acids, cocoa butter, and fatty acids. |
地址 |
Draper UT US |